Share

R-CHOP chemotherapy and intensive CNS prophylaxis

Prospective phase II study of R-CHOP chemotherapy in combination with intensive CNS prophylaxis in patients with Diffused Large B-Cell Lymphoma of the testis (DLBCL) - Code IELSG 30 - EudraCT Number 2009-011789-26

Project Objectives

Phase II study in which all recruited patients undergo chemo-immunotherapy (R-CHOP) associated with the intrathecal infusion of liposomal cytarabine.

Start/End Date

February 17, 2009 - ongoing

Principal Investigator

Prof. Giuseppe Avvisati

Host Institution

IELSG - International Extranodal Lymphoma Study Group

Source of funding

IELSG - International Extranodal Lymphoma Study Group

Project objectives

Studio di fase II in cui tutti i pazienti reclutati vengono sottoposti a chemio-immunoterapia (R-CHOP) associata all’infusione intratecale della citarabina liposomiale.

Start and end date

17/02/2009 - ongoing

Project Manager

Prof. Giuseppe Avvisati

Coordinating institution of the project

IELSG - International Extranodal Lymphoma Study Group

Funding source(s).

IELSG - International Extranodal Lymphoma Study Group

magnifiercrossmenuchevron-downchevron-leftchevron-right